06/19/2026
The DEA is working on new rules for prescribing controlled substances through telemedicine, and one proposal could create serious access problems.
The rule would require clinicians to be physically located in the same state as the patient when prescribing Schedule II medications through telemedicine. That could undercut one of telepsychiatry’s biggest advantages: reaching patients in rural or underserved areas where in-person psychiatric care is limited.
In this clip from our latest episode of The Telepsychiatry Advantage, Dr. Edward Kaftarian explains why this proposed rule could make telepsychiatry less practical for the patients who need it most.
Listen to the full episode on Apple Podcasts, Spotify, and YouTube!
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-telepsychiatry-advantage/id1893377031
Spotify: https://open.spotify.com/show/1sk8JaIhTzOQe9qlAQQPid?si=0b6fd812955c46f9
YouTube: https://www.youtube.com/